Vaccine Safety and Immunogenicity in Patients With Multiple Sclerosis Treated With Natalizumab

by biblioteca on 3 de juny de 2024 with No hi ha comentaris

Carvajal, R., Zabalza, A., Carbonell-Mirabent, P., Martinez-Gómez, X., Esperalba, J., Pappolla, A., . . . Montalban, X., Tintoré, M. (2024). Vaccine Safety and Immunogenicity in Patients With Multiple Sclerosis Treated With Natalizumab. Jama Network Open, 7(4), Article e246345. https://doi.org/10.1001/jamanetworkopen.2024.6345